89bio (ETNB) Competitors

Vaxcyte (NASDAQ:PCVX) and 89bio (NASDAQ:ETNB) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, community ranking, valuation, risk and institutional ownership.

Does the MarketBeat Community prefer PCVX or ETNB?

89bio received 60 more outperform votes than Vaxcyte when rated by MarketBeat users. However, 78.57% of users gave Vaxcyte an outperform vote while only 62.50% of users gave 89bio an outperform vote.

Company	Underperform	Outperform
Vaxcyte	Outperform Votes 55 78.57%	Underperform Votes 15 21.43%
89bio	Outperform Votes 115 62.50%	Underperform Votes 69 37.50%

Do analysts rate PCVX or ETNB?

Vaxcyte currently has a consensus price target of $136.50, suggesting a potential upside of 301.83%. 89bio has a consensus price target of $26.43, suggesting a potential upside of 175.01%. Given Vaxcyte's stronger consensus rating and higher probable upside, analysts plainly believe Vaxcyte is more favorable than 89bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vaxcyte	0 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.10
89bio	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	3.00

Which has more volatility & risk, PCVX or ETNB?

Vaxcyte has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, 89bio has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.

Is PCVX or ETNB more profitable?

Vaxcyte's return on equity of -23.53% beat 89bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vaxcyte	N/A	-23.53%	-22.20%
89bio	N/A	-59.58%	-52.21%

Do insiders and institutionals have more ownership in PCVX or ETNB?

96.8% of Vaxcyte shares are held by institutional investors. 3.1% of Vaxcyte shares are held by company insiders. Comparatively, 2.6% of 89bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media prefer PCVX or ETNB?

In the previous week, Vaxcyte had 10 more articles in the media than 89bio. MarketBeat recorded 15 mentions for Vaxcyte and 5 mentions for 89bio. 89bio's average media sentiment score of 1.76 beat Vaxcyte's score of 1.37 indicating that 89bio is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vaxcyte	13 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
89bio	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has preferable earnings & valuation, PCVX or ETNB?

Vaxcyte is trading at a lower price-to-earnings ratio than 89bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vaxcyte	N/A	N/A	-$402.27M	-$3.99	-8.51
89bio	N/A	N/A	-$142.19M	-$3.38	-2.84

Summary

Vaxcyte beats 89bio on 10 of the 16 factors compared between the two stocks.